The first study on cannabis use for medicinal purposes is underway in the UK with a focus on the benefits it may bring MS sufferers.
A mouth spray called Sativex, which uses cannabis can relieve muscle spasticity, which can make it hard for those afflicted with MS to get out of a car or even open the lid of a milk bottle.
The drug was developed by GW Pharmaceuticals after a few MS sufferers broke the law in an effort to alleviate their pain.
Sativex contains a few active ingredients labelled as cannabinoids, which are taken from cannabis plants gown in top secret at a location in the UK.
About 11,500 MS patients may be eligible to receive the drug with half expect to gleam positive results from its use, but at £11 per day the medicine may not be approved by the NHS rationing body.
For the last few years, a large amount of MS sufferers in Britain have campaigned to be allowed use of cannabis in order to treat their symptoms.
Chief executive of the MS Trust, Pam MacFarlane, stated that they have known for quite some time that cannabis medications may help improve spasticity significantly which is why the MS Trust has been working towards making a licensed medicine available to those who suffer in a prescription manner that can be controlled.
MacFarlane also stated that they have placed a great deal of resources and money in developing the knowledge available by funding research into how effective cannabis medications can be.
Professor John Zajicek, a Derriford Hospital neurology consultant and the world leader in cannabis research stated that the successful treatment was a milestone in just how helpful cannabinoids can be.